Browse by category

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

An analysis of social media posts and a remote study of individuals with obesity who reported using semaglutide and tirzepatide, has...

Semaglutide used in the diabetes drug Ozempic and the weight-management drug Wegovy is not associated with an increased risk for suicidal...

Semaglutide specifically reduces the symptoms of alcohol use disorder (AUD), according to researchers at the University of Oklahoma...

Novo Nordisk is planning a study that will see CagriSema, a new investigational medicine developed by Novo that combines Cagrilintide and...

Semaglutide 2.4mg (Wegovy) reduces cardiovascular events in patients with overweight or obesity and pre-existing cardiovascular disease...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Researchers from the University of California, Irvine, have published a study that projects 93 million US adults that are overweight and...

Two new studies presented at this year's European Congress on Obesity have revealed that semaglutide is effective for weight loss in a...